Traders Look to New Levels Ahead - Research & Analysis on Amgen
Traders Look to New Levels Ahead - Research & Analysis on Amgen Inc. and Glaxosmithkline Plc
JAKARTA, INDONESIA -- (Marketwire) -- 10/23/12 -- Moments ago, TradersInsight.net introduced new coverage of Amgen Inc. (NASDAQ: AMGN) and Glaxosmithkline Plc (NYSE: GSK). Full outlook, analysis and consensus opinion is available to readers via the links below.
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include the spark of U.S. housing starts soaring past expectations to a four-year high in September, industrial production rising 0.4% in September 2012 beating expectations for a 0.2% increase and the recent upward surprise in initial jobless claims bouncing upward to 388,000 above expectations of 365,000 in the latest week. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Traders Insight is releasing new coverage on Amgen Inc. for its current position within the health care sector. Amgen Inc. (Amgen) is a biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for illnesses. It focuses solely on human therapeutics and concentrates on medicines based on cellular and molecular biology. A copy of this report featuring Amgen Inc. (NASDAQ: AMGN) is available at: www.TradersInsight.net/r/cnbc/b737_AMGN.
Traders Insight has released research on Glaxosmithkline Plc for its changing role within the consumer durables sector. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. To access the full research report on Glaxosmithkline Plc (NYSE: GSK) we welcome investors to visit: www.TradersInsight.net/r/cnbc/0771_GSK.
About Traders Insight Find direction and insight with TradersInsight.net. Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result -- we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.
Cora S. Patton press@TradersInsight.net www.TradersInsight.net